PHARMACEUTICAL SCIENCES SJIF Impact Factor: 7.187 IMPORTANCE AND EFFICACY OF LONG ACTING Β2 AGONIST SALMETEROL, IN THE TREATMENT OF MILD TO MODERATE ASTHMA 1 QR code (original ) (raw )A Randomized, Placebo-Controlled Study To Evaluate the Role of Salmeterol in the In-Hospital Management of Asthma
Ridwan Shabsigh
Chest, 2000
View PDFchevron_right
A twelve-week comparison of salmeterol and salbutamol in the treatment of mild-to-moderate asthma: A Canadian multicenter study
Kenneth Chapman
Journal of Allergy and Clinical Immunology, 1997
View PDFchevron_right
A 1-week dose-ranging study of inhaled salmeterol in patients with asthma
Edwin Bronsky
CHEST Journal, 1994
View PDFchevron_right
A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma
Robert Nathan
Annals of Allergy, Asthma & Immunology, 1999
View PDFchevron_right
Effect of long term treatment with salmeterol on asthma control: a double blind, randomised crossover study
Lesley Rushton
BMJ, 1997
View PDFchevron_right
Salmeterol reduces the need for inhaled corticosteroid in steroid-dependent asthmatics
ronald dahl
Respiratory Medicine, 1999
View PDFchevron_right
Tolerance to the protective effect of salmeterol in mild untreated asthmatics
Federico L. Dente
Pulmonary …, 2003
View PDFchevron_right
Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: An analysis of asthma exacerbations
Jonathan Matz
Journal of Allergy and Clinical Immunology, 2001
View PDFchevron_right
The Salmeterol Multicenter Asthma Research Trial* A Comparison of Usual Pharmacotherapy for Asthma …
Harold Nelson
Chest, 2006
View PDFchevron_right
Salmeterol does not cause tolerance during long-term asthma therapy
Edmundo Stahl
Journal of allergy and …, 1996
View PDFchevron_right
Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma
Paul Chervinsky
Annals of Allergy, Asthma & Immunology, 1999
View PDFchevron_right
Combined Salmeterol/Fluticasone Propionate versus Fluticasone Propionate Alone in Mild Asthma: A Placebo-Controlled Comparison
Watchara Boonsawat
Clinical Drug Investigation, 2008
View PDFchevron_right
Salmeterol/fluticasone propionate (50/250 microg) combination is superior to double dose fluticasone (500 microg) for the treatment of symptomatic moderate asthma
Karl-Christian Bergmann
Swiss medical weekly, 2004
View PDFchevron_right
Salmeterol in the treatment of childhood asthma
Anja Vaessen-Verberne
1997
View PDFchevron_right
Initiation of maintenance treatment with salmeterol/fluticasone propionate 50/100μg bd versus fluticasone propionate 100μg bd alone in patients with persistent asthma: Integrated analysis of four randomised trials
C. Goldfrad
Respiratory Medicine, 2007
View PDFchevron_right
Effect of Long-term Salmeterol Therapy Compared With As-Needed Albuterol Use on Airway Hyperresponsiveness
Richard Rosenthal
Chest, 1999
View PDFchevron_right
Long-term treatment of asthmatic patients with salmeterol vs slow-release theophylline
roberto nutini
Respiratory Medicine, 1998
View PDFchevron_right
Addition of Salmeterol or Theophylline to an Inhaled Corticosteroid Regimen in Patients With Severe Asthma
Nurgül Bozkurt
2002
View PDFchevron_right
Potential Masking Effects of Salmeterol on Airway Inflammation in Asthma
Emílio Pizzichini
American Journal of Respiratory and Critical Care Medicine, 1998
View PDFchevron_right
Improvement in asthma endpoints when aiming for total control: salmeterol/fluticasone propionate versus fluticasone propionate alone
Watchara Boonsawat
Primary Care Respiratory Journal, 2007
View PDFchevron_right
Prescription Patterns in Asthma Patients Initiating Salmeterol in UK General Practice
Rachael Disantostefano
Drug Safety, 2011
View PDFchevron_right
[Evaluation of the clinical efficacy and the safety of salmeterol/fluticasone propionate accuhaler compared to budesonide turbuhalar in the control of adult asthma]
Fabrizia Veronesi
Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2005
View PDFchevron_right
A comparison of regular salmeterol vs ‘as required’ salbutamol therapy in asthmatic children
Andrea von Berg
Respiratory Medicine, 1998
View PDFchevron_right
Meta-analysis: Effects of Adding Salmeterol to Inhaled Corticosteroids on Serious Asthma-Related Events
Eric Bateman
Annals of Internal Medicine, 2008
View PDFchevron_right
Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma
Jaring Van Der Zee
Thorax, 2006
View PDFchevron_right
Global Initiative for Asthma 2016–derived asthma control with fluticasone propionate and salmeterol
nadeem gul
Annals of Allergy, Asthma & Immunology, 2019
View PDFchevron_right
EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma
Alexander Chuchalin
Respiratory Medicine, 2006
View PDFchevron_right
Evaluation of Salmeterol or Montelukast as Second-Line Therapy for Asthma Not Controlled With Inhaled Corticosteroids
Erika Sims
Chest, 2001
View PDFchevron_right
Comparison of salmeterol/fluticasone propionate (FP) combination with FP+sustained release theophylline in moderate asthma patients
Ken Ohta
Respiratory Medicine, 2008
View PDFchevron_right